Optovue Technology and “Firsts” in OCT
Optovue Technology and “Firsts” in OCTThe Avanti embodies many of the “Firsts” in SD-OCT development that Optovue has introduced to eye care, including the first FDA Cleared SD-OCT, 2-phase Noise Reduction, Mode switching to image the inner retina or the deep choroid, Choroid imaging and measurement, Anterior Segment imaging and measurement, GCC with FLV and GLV, Enface Analysis of 3D data, Pachymetry Mapping, Total Cornea Power measurement and more (See “18 TRUTHS” book).
The Avanti SD-OCT allows eye care practitioners at all levels to offer the most current technology, and stay ahead of clinical challenges with confidence. The forward thinking development encompassed in the Avanti also provides clinicians with the basis to move to the next level in clinical OCT utility… functional OCT.
The New Standard in OCT Imaging
- 70,000 A-scans/second
- Widefield 3D OCT Imaging (12mm x 9mm)
- 320×320 3D cube
- 28μm B-scan spacing
- SMART™ motion correction processing
- 3mm scanning window depth
- Enhanced HD Vitreous & Choroidal imaging
- SharpVue™ processing
- VTRAC Real-time tracking
- Deep Choroidal Imaging (DCI)
- Fovea Location Recognition (FLR)
- TREND analysis for Nerve Fiber & Central Macula
- Pachymetry map of cornea (6mm)
- Total Cornea Power (TCP)
- Epithelium Thickness Map* (ETM™) of cornea (6mm)
*ETM™ (Epithelium Thickness map is pending FDA 510(k) Clearance.